140 results
Page 2 of 7
8-K
EX-99.1
4i7hy5
14 Aug 23
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
7:30am
8-K
EX-99.1
0e7urx4xl e1doae
22 May 23
Gamida Cell Appoints Terry Coelho as CFO
8:55am
8-K
EX-3.1
kiy9xr6 2a
19 May 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-99.1
0vyv9dlidyrbnjalmgoj
15 May 23
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
12:00am
8-K
EX-1.1
1f1f7tfl dgmb
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.1
pk0tp8d4b4n78 5jwc
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.2
n62qna4twwd7d14n ki4
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.1
czhz01gn2juv aqhsbg6
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
8-K
EX-10.1
hp0m3st7eq0dzlsqy
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-99.1
1ce cv4fz7
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-99.1
k9gijbb1
21 Nov 22
Gamida Cell Provides Regulatory Update on Omidubicel
5:20pm
8-K
EX-99.1
53dnk
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
ezc8un 0osrm
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
8-K
EX-1.1
fongcdj44gdr3
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm